The effects of inhaled procaterol on COPD patients.
Not Applicable
- Conditions
- Chronic obstructive pulmonary disease (COPD)
- Registration Number
- JPRN-UMIN000003174
- Lead Sponsor
- St.Marianna University School of Medicine Respiratory and Infectious Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
History of exacerbation in the previous 8 weeks Co-morbid conditions (heart diseases or neuromuscular diseases) limiting exercise. The other significant conditions that seem to limit study protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The collerations between clinical and functional parameters and the effects procaterol inhalation on lung function, dyapnea and exercise performance (6MW) in patients with COPD .
- Secondary Outcome Measures
Name Time Method Adverse event